Skip to main content
. Author manuscript; available in PMC: 2014 Sep 4.
Published in final edited form as: Thromb Res. 2011 Dec 7;130(1):27–31. doi: 10.1016/j.thromres.2011.11.025

Table 1.

Patient characteristics.

Characteristic Classification % (Number)
Age (Years) 0–29 0.3 (9/3572)
(Median 62) 30–49 21.0 (750/3572)
50–59 23.8 (850/3572)
60–69 24.7 (882/3572)
70–79 21.0 (751/3572)
80+ 9.2 (330/3572)
Body mass index (kg/m2) (Median 28.6) Underweight: < 18.5 1.2% (34/2866)
Normal: 18.5 – 24.9 25.4% (729/2866)
Overweight: 25.0 – 29.9 31.6% (906/2866)
Obese: 30.0 – 39.9 34.3% (983/2866)
Extremely Obese: ≥ 40.0 7.5% (214/2866)
Blood Pressure (mmHg) (Median 130/76) Normal: SBP <120, DBP <80 23.4% (757/3237)
Prehypertension: SBP 120–139, DBP 80–89 41.5% (1344/3237)
Stage 1 Hypertension: SBP 140–159, DBP 90–99 28.2% (913/3237)
Stage 2 Hypertension: SBP >160, DBP>100 6.9% (223/3237)
LDL (mg/dL) (Median 117) Optimal: <100 31.3% (760/2427)
Near Optimal: 100–129 31.7% (770/2427)
Borderline: 130–159 23.4% (567/2427)
High: 160–189 9.8% (237/2427)
Very High: >190 3.8% (93/2427)
HDL (mg/dL) (Median 54) Low: <40 14.3% (355/2480)
Optimal: 40–60 49.0% (1214/2480)
High: >60 36.7% (911/2480)
Total Cholesterol (mg/dL) (Median 196) Desirable:<200 54.1% (1534/2835)
Borderline: 200–239 30.6% (867/2835)
High: >240 15.3% (434/2835)
Triglyceride (mg/dL) (Median 129) Normal: <150 60.2% (1509/2505)
Borderline-high: 150–199 17.6% (442/2505)
High: 200–499 20.6% (515/2505)
Very high: ≥ 500 1.6% (39/2505)
Statin Use 37.0% (1322/3572)
Diabetes 13.8% (494/3572)
Smoking 41.1% (907/2207)
Hormone Replacement Therapy 17.9% (639/3572)

SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein